687 related articles for article (PubMed ID: 29482604)
1. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
[TBL] [Abstract][Full Text] [Related]
2. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
Pradhan V; Mahant G; Rajadhyaksha A; Surve P; Rajendran V; Patwardhan M; Nadkarni A; Dighe S; Ghosh K
Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
[TBL] [Abstract][Full Text] [Related]
4. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
Lourdudoss C; Ajeganova S; Frostegård J
Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
[TBL] [Abstract][Full Text] [Related]
5. Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE.
Ye Y; Wu T; Zhang T; Han J; Habazi D; Saxena R; Mohan C
Clin Immunol; 2019 Aug; 205():43-48. PubMed ID: 31075396
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
7. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
Gunnarsson I; Rönnelid J; Huang YH; Rogberg S; Nilsson B; Lundberg I; Klareskog L
Br J Rheumatol; 1997 Jan; 36(1):32-7. PubMed ID: 9117171
[TBL] [Abstract][Full Text] [Related]
8. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
[TBL] [Abstract][Full Text] [Related]
10. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
11. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
[TBL] [Abstract][Full Text] [Related]
12. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
[TBL] [Abstract][Full Text] [Related]
13. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
14. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
[TBL] [Abstract][Full Text] [Related]
16. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.
Saxena R; Sturfelt G; Nived O; Wieslander J
Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578
[TBL] [Abstract][Full Text] [Related]
17. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
18. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis.
Chuang HC; Chen YM; Hung WT; Li JP; Chen DY; Lan JL; Tan TH
Oncotarget; 2016 Sep; 7(36):57593-57605. PubMed ID: 27557500
[TBL] [Abstract][Full Text] [Related]
20. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
